Treatment of infantile primary pulmonary hypertension by intravenous infusion of lipo-prostaglandin I2 analog.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9152299.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We used a new vasodilator, TTC-909 (a prostaglandin I2 analog incorporated in lipid microspheres), which produced marked reduction in the pulmonary arterial pressure and resistance in an infant with primary pulmonary hypertension.
Medical subject headings
- Epoprostenol
- Hypertension, Pulmonary
- Vasodilator Agents